Eton Pharmaceuticals (ETON) Inventory Average (2020 - 2025)

Eton Pharmaceuticals has disclosed Inventory Average across 6 years of filings, most recently posting $16.1 million for Q4 2025.

• Inventory Average for Q4 2025 came in at $16.1 million, up 87.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.1 million (up 87.97% YoY), and the FY2025 annual result was $15.3 million, up 89.87% from the prior year.
• Inventory Average came in at $16.1 million for Q4 2025 at Eton Pharmaceuticals, down from $20.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $20.3 million in Q3 2025 to a low of $442000.0 in Q4 2021.
• The 5-year median for Inventory Average is $1.1 million (2021), against an average of $4.6 million.
• Across the five-year window, Inventory Average tumbled 69.94% in 2021 and surged 914.63% in 2025, its largest moves.
• Eton Pharmaceuticals' Inventory Average stood at $442000.0 in 2021, then climbed by 17.42% to $519000.0 in 2022, then surged by 89.02% to $981000.0 in 2023, then soared by 775.13% to $8.6 million in 2024, then jumped by 87.97% to $16.1 million in 2025.
• The last three Inventory Average figures came in at $16.1 million (Q4 2025), $20.3 million (Q3 2025), and $18.7 million (Q2 2025), per Business Quant data.